CRDF 002
Alternative Names: CRDF-002Latest Information Update: 09 Oct 2023
At a glance
- Originator Guangzhou Zhaoke Lian Fa Pharmaceutical
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Registered Unspecified
Most Recent Events
- 04 Oct 2023 Registered for Unspecified rare disease in China (unspecified route) prior to October 2023 (Lee's Pharmaceutical pipeline, October 2023)
- 01 Mar 2021 Preregistration for Unspecified in China (Unspecified) (Lee's Pharmaceuticals pipeline, March 2021)